Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Vir Biotechnology (NASDAQ: VIR) has announced that its CEO Marianne De Backer will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference in Miami, Florida. The event is scheduled for Tuesday, December 3, at 6:10 a.m. PT / 9:10 a.m. ET. A live webcast of the discussion will be available on the company's website under the Investors section and will remain accessible for 30 days following the event.
Vir Biotechnology (NASDAQ: VIR) ha annunciato che il suo CEO Marianne De Backer parteciperà a un incontro informale nell'ambito del 7° Annual Evercore ISI HealthCONx Conference a Miami, Florida. L'evento è programmato per martedì 3 dicembre, alle 6:10 PT / 9:10 ET. Una trasmissione in diretta della discussione sarà disponibile sul sito web dell'azienda nella sezione dedicata agli Investitori e rimarrà accessibile per 30 giorni dopo l'evento.
Vir Biotechnology (NASDAQ: VIR) ha anunciado que su CEO Marianne De Backer participará en una charla informal en la 7ª Conferencia Anual Evercore ISI HealthCONx en Miami, Florida. El evento está programado para el martes 3 de diciembre, a las 6:10 a.m. PT / 9:10 a.m. ET. Una transmisión en vivo de la discusión estará disponible en el sitio web de la compañía en la sección de Inversores y permanecerá accesible durante 30 días después del evento.
Vir Biotechnology (NASDAQ: VIR)는 CEO Marianne De Backer가 플로리다주 마이애미에서 열리는 제7회 Evercore ISI HealthCONx 컨퍼런스에서 대화에 참여할 것이라고 발표했습니다. 이 행사는 12월 3일 화요일, 오전 6:10 PT / 오전 9:10 ET로 예정되어 있습니다. 토론의 실시간 웹캐스트를 회사 웹사이트의 투자자 섹션에서 제공할 예정이며, 행사 후 30일 동안 접근할 수 있습니다.
Vir Biotechnology (NASDAQ: VIR) a annoncé que sa CEO Marianne De Backer participera à une discussion informelle lors de la 7ème Conférence Annuelle Evercore ISI HealthCONx à Miami, en Floride. L'événement est prévu pour le mardi 3 décembre à 6h10 PT / 9h10 ET. Une diffusion en direct de la discussion sera disponible sur le site web de l'entreprise dans la section Investisseurs et restera accessible pendant 30 jours suivant l'événement.
Vir Biotechnology (NASDAQ: VIR) hat bekannt gegeben, dass ihre CEO Marianne De Backer an einem Fireside-Chat auf der 7. jährlichen Evercore ISI HealthCONx-Konferenz in Miami, Florida, teilnehmen wird. Die Veranstaltung ist für Dienstag, den 3. Dezember, um 6:10 Uhr PT / 9:10 Uhr ET angesetzt. Ein Live-Stream der Diskussion wird auf der Website des Unternehmens im Bereich Investoren verfügbar sein und bleibt 30 Tage nach der Veranstaltung zugänglich.
- None.
- None.
A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Vir Biotechnology’s clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and programs across several clinically validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241125578049/en/
Media
Arran Attridge
Senior Vice President, Corporate Communications
aattridge@vir.bio
Investors
Richard Lepke
Senior Director, Investor Relations
rlepke@vir.bio
Source: Vir Biotechnology, Inc.
FAQ
When is Vir Biotechnology (VIR) presenting at the Evercore ISI HealthCONx Conference?
Where can I watch Vir Biotechnology's (VIR) Evercore Conference presentation?
Who is representing Vir Biotechnology (VIR) at the Evercore HealthCONx Conference?
Where is the 7th Annual Evercore ISI HealthCONx Conference being held for VIR's presentation?
